Goldman Sachs analyst maintains Buy rating on Pfizer with $33 price target. Discusses update on 2nd-gen C. diff vaccine in ...

PCV21 is the first pneumococcal conjugate vaccine candidate with more than 20 serotypes to enter a Phase III clinical trial in infants and toddlers. Sanofi and SK Bioscience announced that they have ...

Among the primary approaches are adoptive cell therapy, immune checkpoint inhibitors (ICIs), and cancer vaccines. Cancer vaccines introduce tumor antigens that activate T-cells, which then target ...

“We’re seeing a drop in vaccine coverage alongside emerging strains of the bacterium and antibiotic resistance. “It’s important to recognise that effective pneumococcal vaccination helps ...

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...

The pneumococcal conjugate vaccine—known ... which lack support from organizations like Gavi, the vaccine alliance, and Pan American Health Organization (PAHO). Our region has been the slowest ...

“New generation vaccines need to be rolled out through the National Immunisation Program without further delay. We simply can’t risk not having the best available pneumococcal protection ...

Nigeria is set to receive 11,200 doses of Mpox vaccine, donated by the United States of America and facilitated by Gavi, the Vaccine Alliance. Gavi, on its website, reported that the vaccine has ...

Rates of invasive pneumococcal disease are at their highest levels since 2004. While more effective vaccines have been approved for use in Australia, most at-risk people can't get them ...

A Dec. 10 Instagram post (direct link, archive link) claims Robert F Kennedy Jr.'s comments on vaccines have been limited to advocating for more research. "RFK is saying one thing and one thing ...